The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease†
Open accessAbstract
UNLABELLED: There have been important advances in defining effector mechanisms for several human autoimmune diseases. However, for most human autoimmune diseases, the induction stage is less well defined and there are very few clues on etiology. Our laboratory has focused on defining the molecular basis of autoantibody recognition and epitope modification in primary biliary cirrhosis (PBC). Our work has demonstrated that antibodies to mitochondria, the hallmark of disease, are directed against a very conserved site of pyruvate dehydrogenase, the E2 subunit of pyruvate dehydrogenase (PDC-E2). We have also demonstrated that several chemical xenobiotics, chosen based on quantitative structural activity relationship analysis and rigorous epitope analysis, when coupled to the lysine residue that normally binds the lipoic acid cofactor of PDC-E2, reacts as well or better to PBC sera than native autoantigen. In the present studies, we immunized C57BL/6 mice with one such xenobiotic, 2-octynoic acid, coupled to bovine serum albumin and we followed the mice for 24 weeks. Animals were studied for appearance of histologic lesions as well as appearance of antibodies to PDC-E2, serum levels of tumor necrosis factor-alpha and interferon-gamma, and splenic and liver lymphoid phenotyping by flow cytometry. Mice immunized with 2-octynoic acid manifest autoimmune cholangitis, typical mitochondrial autoantibodies, increased liver lymphoid cell numbers, an increase in CD8(+) liver infiltrating cells, particularly CD8(+) T cells that coexpress CD44, and finally an elevation of serum tumor necrosis factor-alpha and interferon-gamma. CONCLUSION: these data provide a persuasive argument in favor of an environmental origin for human PBC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Primary biliary cirrhosis in monozygotic and dizygotic twins: Genetics, epigenetics, and environment
Selmi, C., Mayo, M. J., Bach, N., Ishibashi, H., Invernizzi, P., Gish, R. G., Gordon, S. C., Wright, H. I., Zweiban, B., Podda, M., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.05.005 · Cited by 480
Self-citationPatients With Primary Biliary Cirrhosis React Against A Ubiquitous Xenobiotic–Metabolizing Bacterium
Selmi, C., Balkwill, D. L., Invernizzi, P., Ansari, A. A., Coppel, R. L., Podda, M., Leung, P. S., Kenny, T. P., Van De Water, J., Nantz, M. H., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50446 · Cited by 312
Self-citationIL-2 receptor α−/− mice and the development of primary biliary cirrhosis
Wakabayashi, K., Lian, Z.-X., Moritoki, Y., Lan, R. Y., Tsuneyama, K., Chuang, Y.-H., Yang, G.-X., Ridgway, W., Ueno, Y., Ansari, A. A., et al. (2006) · Hepatology · doi:10.1002/hep.21385 · Cited by 233
Self-citationKita, H., Matsumura, S., He, X.-S., Ansari, A. A., Lian, Z.-X., Van de Water, J., Coppel, R. L., Kaplan, M. M., & Gershwin, M. E. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214698 · Cited by 222
Self-citationAmano, K., Leung, P. S. C., Rieger, R., Quan, C., Wang, X., Marik, J., Suen, Y. F., Kurth, M. J., Nantz, M. H., Ansari, A. A., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5874 · Cited by 187
Self-citationMoteki, S., Leung, P. S., Coppel, R. L., Dickson, E. R., Kaplan, M. M., Munoz, S., & Gershwin, M. E. (1996) · Hepatology · doi:10.1002/hep.510240117 · Cited by 152
Self-citation
Research works printed but not linked: 29
- Leung, 2003, Is there a relation between Chlamydia infection and primary biliary cirrhosis?, Clin Dev Immunol, 10, 227
- Padgett, 2005, Phylogenetic and immunological definition of four lipoylated proteins from Novosphingobium aromaticivorans, implications for primary biliary cirrhosis, J Autoimmun, 24, 209, 10.1016/j.jaut.2005.01.012 · DOI
- Amano, 2004, Xenobiotic‐induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible, J Immunol, 172, 6444, 10.4049/jimmunol.172.10.6444 · DOI
- Gershwin, 2008, The causes of primary biliary cirrhosis: convenient and inconvenient truths, HEPATOLOGY, 47, 737, 10.1002/hep.22042 · DOI · Paper page
- Leung, 2007, Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization, J Immunol, 179, 2651, 10.4049/jimmunol.179.4.2651 · DOI
- Leung, 2003, Immunization with a xenobiotic 6‐bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies, J Immunol, 170, 5326, 10.4049/jimmunol.170.10.5326 · DOI
- Long, 2001, Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis, J Immunol, 167, 2956, 10.4049/jimmunol.167.5.2956 · DOI · Paper page
- Rieger, 2007, The X and why of xenobiotics in primary biliary cirrhosis, J Autoimmun, 28, 76, 10.1016/j.jaut.2007.02.003 · DOI
- Rieger, 2006, Identification of 2‐nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis, J Autoimmun, 27, 7, 10.1016/j.jaut.2006.06.002 · DOI · Paper page
- Migliaccio, 1998, Monoclonal antibodies to mitochondrial E2 components define autoepitopes in primary biliary cirrhosis, J Immunol, 161, 5157, 10.4049/jimmunol.161.10.5157 · DOI
- Migliaccio, 2001, Heterogeneous response of antimitochondrial autoantibodies and bile duct apical staining monoclonal antibodies to pyruvate dehydrogenase complex E2: the molecule versus the mimic, HEPATOLOGY, 33, 792, 10.1053/jhep.2001.23783 · DOI
- Irie, 2006, NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis, J Exp Med, 203, 1209, 10.1084/jem.20051911 · DOI · Paper page
- Koarada, 2004, Genetic control of autoimmunity: protection from diabetes, but spontaneous autoimmune biliary disease in a nonobese diabetic congenic strain, J Immunol, 173, 2315, 10.4049/jimmunol.173.4.2315 · DOI
- Chuang, 2008, Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant‐negative mouse model of primary biliary cirrhosis, HEPATOLOGY, 47, 571, 10.1002/hep.22052 · DOI
- Oertelt, 2006, Anti‐mitochondrial antibodies and primary biliary cirrhosis in TGF‐beta receptor II dominant‐negative mice, J Immunol, 177, 1655, 10.4049/jimmunol.177.3.1655 · DOI · Paper page
- Yang, 2008, Adoptive transfer of CD8+ T cells from transforming growth factor bet receptor type II (dominant negative form) induces autoimmune cholangitis in mice, HEPATOLOGY, 47, 1974, 10.1002/hep.22226 · DOI
- Okada, 2005, Early development of primary biliary cirrhosis in female C57BL/6 mice because of poly I:C administration, Liver Int, 25, 595, 10.1111/j.1478-3231.2005.01043.x · DOI
- Ide, 1996, An experimental animal model of primary biliary cirrhosis induced by lipopolysaccharide and pyruvate dehydrogenase, Kurume Med J, 43, 185, 10.2739/kurumemedj.43.185 · DOI
- Kimura, 1996, Monoclonal antibody against lymphocyte function‐associated antigen 1 inhibits the formation of primary biliary cirrhosis‐like lesions induced by murine graft‐versus‐host reaction, HEPATOLOGY, 24, 888
- Jones, 2000, Experimental autoimmune cholangitis: a mouse model of immune‐mediated cholangiopathy, Liver, 20, 351, 10.1034/j.1600-0676.2000.020005351.x · doi:10.1034/j.1600-0676.2000.020005351.x
- Jones, 1999, Breakdown of tolerance to pyruvate dehydrogenase complex in experimental autoimmune cholangitis: a mouse model of primary biliary cirrhosis, HEPATOLOGY, 30, 65, 10.1002/hep.510300123 · DOI
- Sasaki, 2002, The SJL/J mouse is not a model for PBC, HEPATOLOGY, 35, 1284, 10.1053/jhep.2002.32540 · doi:10.1053/jhep.2002.32540
- Tanaka, 2001, Genetic and familial considerations of primary biliary cirrhosis, Am J Gastroenterol, 96, 8, 10.1111/j.1572-0241.2001.03446.x · DOI
- Sohn, 2007, Apoptosis during negative selection of autoreactive thymocytes, Curr Opin Immunol, 19, 510, 10.1016/j.coi.2007.06.001 · DOI
- Segal, 2003, The effect of IL‐12 on clinical and laboratory aspects of experimental SLE in young and aging mice, Exp Gerontol, 38, 661, 10.1016/S0531-5565(03)00060-3 · doi:10.1016/s0531-5565(03)00060-3
- Lan, 2006, Liver‐targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis, HEPATOLOGY, 43, 729, 10.1002/hep.21123 · DOI · Paper page
- Van de Water, 1993, Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross‐reactive with pyruvate dehydrogenase complex‐E2, J Clin Invest, 91, 2653, 10.1172/JCI116504 · DOI · Paper page
- Krams, 1989, Immunization of experimental animals with dihydrolipoamide acetyltransferase, as a purified recombinant polypeptide, generates mitochondrial antibodies but not primary biliary cirrhosis, HEPATOLOGY, 9, 411, 10.1002/hep.1840090311 · DOI
- Opdyke, 1979, Monographs on fragrance raw materials, Food Cosmet Toxicol, 17, 357, 10.1016/0015-6264(79)90330-4 · doi:10.1016/0015-6264(79)90330-4
Cited by
Lindor, K. D., Bowlus, C. L., Boyer, J., Levy, C., & Mayo, M. (2019) · Hepatology · doi:10.1002/hep.30145 · Cited by 913
Molecular mimicry and autoimmunity
Rojas, M., Restrepo-Jiménez, P., Monsalve, D. M., Pacheco, Y., Acosta-Ampudia, Y., Ramírez-Santana, C., Leung, P. S. C., Ansari, A. A., Gershwin, M. E., & Anaya, J.-M. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.10.012 · Cited by 627
Self-citationSelmi, C., Bowlus, C. L., Gershwin, M. E., & Coppel, R. L. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61965-4 · Cited by 334
Self-citationThe immunobiology and pathophysiology of primary biliary cirrhosis
Hirschfield, G. M., & Gershwin, M. E. (2013) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-164014 · Cited by 315
Self-citationPrimary biliary cholangitis: pathogenesis and therapeutic opportunities
Gulamhusein, A. F., & Hirschfield, G. M. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0226-7 · Cited by 308
Metadata
- Authors
- Wakabayashi, K., Lian, Z., Leung, P. S. C., Moritoki, Y., Tsuneyama, K., Kurth, M. J., Lam, K. S., Yoshida, K., Yang, G., Hibi, T., Ansari, A. A., Ridgway, W. M., Coppel, R. L., Mackay, I. R., & Gershwin, M. E.
- Venue
- Hepatology
- Published
- 2008-08
- Volume
- 48
- Issue
- 2
- Pages
- 531-540
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2084419632
- Cited by
- 180
- References
- 6
- FWCI
- 9.95
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 2587 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.